トラベルワクチン市場は、2022年から2027年の間に37億1,553万米ドル成長すると予測されており、予測期間中にCAGRは8.64%で加速します。トラベルワクチン市場に関するレポートでは、全体的な分析、市場規模と予測、傾向、成長推進要因、課題のほか、約25社のベンダーを対象としたベンダー分析も提供しています。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、世界的な移民の増加、旅行者の間でのワクチンで予防可能な病気に対する意識の高まり、ビザ発給前のワクチン接種に対する各国の義務によって牽引されています。
この調査では、今後数年間のトラベルワクチン市場成長を牽引する主な要因の1つとして、世界の旅行者の人口動態の変化を挙げています。また、旅行に関連する疾病の発生率の増加や、旅行の安全性を確保するための政府やその他の組織による取り組みも、市場の大きな需要につながります。
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、トラベルワクチン市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global travel vaccines market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2017 - 2021 ($ million)
4.2 Disease Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Disease Type Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Disease Type
6.1 Market segments
Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)
6.2 Comparison by Disease Type
Exhibit 32: Chart on Comparison by Disease Type
Exhibit 33: Data Table on Comparison by Disease Type
6.3 Influenza - Market size and forecast 2022-2027
Exhibit 34: Chart on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Influenza - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Influenza - Year-over-year growth 2022-2027 (%)
6.4 Diphtheria - Market size and forecast 2022-2027
Exhibit 38: Chart on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Diphtheria - Year-over-year growth 2022-2027 (%)
6.5 Hepatitis - Market size and forecast 2022-2027
Exhibit 42: Chart on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2022-2027 (%)
6.6 Typhoid and others - Market size and forecast 2022-2027
Exhibit 46: Chart on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Disease Type
Exhibit 50: Market opportunity by Disease Type ($ million)
Exhibit 51: Data Table on Market opportunity by Disease Type ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Adult vaccines - Market size and forecast 2022-2027
Exhibit 56: Chart on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2022-2027 (%)
7.4 Pediatric vaccines - Market size and forecast 2022-2027
Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 AstraZeneca Plc
Exhibit 120: AstraZeneca Plc - Overview
Exhibit 121: AstraZeneca Plc - Product / Service
Exhibit 122: AstraZeneca Plc - Key news
Exhibit 123: AstraZeneca Plc - Key offerings
12.5 Bharat Biotech Ltd.
Exhibit 124: Bharat Biotech Ltd. - Overview
Exhibit 125: Bharat Biotech Ltd. - Product / Service
Exhibit 126: Bharat Biotech Ltd. - Key news
Exhibit 127: Bharat Biotech Ltd. - Key offerings
12.6 CSL Ltd.
Exhibit 128: CSL Ltd. - Overview
Exhibit 129: CSL Ltd. - Business segments
Exhibit 130: CSL Ltd. - Key news
Exhibit 131: CSL Ltd. - Key offerings
Exhibit 132: CSL Ltd. - Segment focus
12.7 Dynavax Technologies Corp.
Exhibit 133: Dynavax Technologies Corp. - Overview
Exhibit 134: Dynavax Technologies Corp. - Product / Service
Exhibit 135: Dynavax Technologies Corp. - Key offerings
12.8 GlaxoSmithKline Plc
Exhibit 136: GlaxoSmithKline Plc - Overview
Exhibit 137: GlaxoSmithKline Plc - Business segments
Exhibit 138: GlaxoSmithKline Plc - Key news
Exhibit 139: GlaxoSmithKline Plc - Key offerings
Exhibit 140: GlaxoSmithKline Plc - Segment focus
12.9 KM Biologics Co. Ltd.
Exhibit 141: KM Biologics Co. Ltd. - Overview
Exhibit 142: KM Biologics Co. Ltd. - Product / Service
Exhibit 143: KM Biologics Co. Ltd. - Key offerings
12.10 LG Chem Ltd.
Exhibit 144: LG Chem Ltd. - Overview
Exhibit 145: LG Chem Ltd. - Business segments
Exhibit 146: LG Chem Ltd. - Key news
Exhibit 147: LG Chem Ltd. - Key offerings
Exhibit 148: LG Chem Ltd. - Segment focus
12.11 Merck and Co. Inc.
Exhibit 149: Merck and Co. Inc. - Overview
Exhibit 150: Merck and Co. Inc. - Business segments
Exhibit 151: Merck and Co. Inc. - Key news
Exhibit 152: Merck and Co. Inc. - Key offerings
Exhibit 153: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 154: Novartis AG - Overview
Exhibit 155: Novartis AG - Business segments
Exhibit 156: Novartis AG - Key offerings
Exhibit 157: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product / Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 162: Sanofi SA - Overview
Exhibit 163: Sanofi SA - Business segments
Exhibit 164: Sanofi SA - Key news
Exhibit 165: Sanofi SA - Key offerings
Exhibit 166: Sanofi SA - Segment focus
12.15 Serum Institute of India Pvt. Ltd.
Exhibit 167: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 168: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 169: Serum Institute of India Pvt. Ltd. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Valneva SE
Exhibit 174: Valneva SE - Overview
Exhibit 175: Valneva SE - Business segments
Exhibit 176: Valneva SE - Key offerings
Exhibit 177: Valneva SE - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global travel vaccines market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Disease Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Influenza - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Influenza - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Disease Type ($ million)
Exhibits51: Data Table on Market opportunity by Disease Type ($ million)
Exhibits52: Chart on End-user - Market share 2022-2027 (%)
Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Bharat Biotech Ltd. - Overview
Exhibits125: Bharat Biotech Ltd. - Product / Service
Exhibits126: Bharat Biotech Ltd. - Key news
Exhibits127: Bharat Biotech Ltd. - Key offerings
Exhibits128: CSL Ltd. - Overview
Exhibits129: CSL Ltd. - Business segments
Exhibits130: CSL Ltd. - Key news
Exhibits131: CSL Ltd. - Key offerings
Exhibits132: CSL Ltd. - Segment focus
Exhibits133: Dynavax Technologies Corp. - Overview
Exhibits134: Dynavax Technologies Corp. - Product / Service
Exhibits135: Dynavax Technologies Corp. - Key offerings
Exhibits136: GlaxoSmithKline Plc - Overview
Exhibits137: GlaxoSmithKline Plc - Business segments
Exhibits138: GlaxoSmithKline Plc - Key news
Exhibits139: GlaxoSmithKline Plc - Key offerings
Exhibits140: GlaxoSmithKline Plc - Segment focus
Exhibits141: KM Biologics Co. Ltd. - Overview
Exhibits142: KM Biologics Co. Ltd. - Product / Service
Exhibits143: KM Biologics Co. Ltd. - Key offerings
Exhibits144: LG Chem Ltd. - Overview
Exhibits145: LG Chem Ltd. - Business segments
Exhibits146: LG Chem Ltd. - Key news
Exhibits147: LG Chem Ltd. - Key offerings
Exhibits148: LG Chem Ltd. - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: Sanofi SA - Overview
Exhibits163: Sanofi SA - Business segments
Exhibits164: Sanofi SA - Key news
Exhibits165: Sanofi SA - Key offerings
Exhibits166: Sanofi SA - Segment focus
Exhibits167: Serum Institute of India Pvt. Ltd. - Overview
Exhibits168: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits169: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits174: Valneva SE - Overview
Exhibits175: Valneva SE - Business segments
Exhibits176: Valneva SE - Key offerings
Exhibits177: Valneva SE - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations
